Cancer

(iStock)
April 22, 2026

Liquid biopsy predicts response to breast cancer immunotherapy

This minimally invasive and cost-effective alternative to tissue biopsy offers “an accessible tool for tailoring treatment strategies in breast cancer,” researchers reported April 22 in the journal Science Translational Medicine.

By Bill Snyder
April 14, 2026

Genomic testing finds a higher prevalence of high-risk breast cancer in Black women

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

By Bill Snyder
April 9, 2026

How robotic bronchoscopy helped a Georgia man avoid unnecessary lung surgery

Oncologist Mohamed Shanshal, MD, said robotic bronchoscopy significantly improves getting patients the appropriate treatment as soon as possible, reducing their anxiety and improving care.

By Jill Clendening
April 7, 2026

Sickle cell disease heightens risk for precancerous blood disorder

These findings shed light on disruptions in normal blood cell development (hematopoiesis) that may be shared by sickle cell disease and clonal hematopoiesis.

By Bill Snyder
March 20, 2026

Study shows AI-assisted risk model for lung nodules is cost-effective

Risk prediction software using artificial intelligence can help determine whether pulmonary nodules detected during lung cancer screening need to be biopsied.

By Tom Wilemon
(iStock image)
March 20, 2026

Precancerous blood disorder raises risk of inflammatory heart disease

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

By Bill Snyder